About CVRx
CVRx is a company based in Minneapolis (United States) founded in 2001.. CVRx has raised $368.5 million across 9 funding rounds from investors including SVB, DaVita and Oxford Finance. The company has 206 employees as of December 31, 2024. CVRx offers products and services including Barostim. CVRx operates in a competitive market with competitors including Sequana Medical, Adona Medical, Element Science, V-Wave and Ancora Heart, among others.
- Headquarter Minneapolis, United States
- Employees 206 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cvrx, Inc.
-
Annual Revenue
$51.29 M30.53as on Dec 31, 2024
-
Net Profit
$-59.97 M-45.55as on Dec 31, 2024
-
EBITDA
$-58.87 M-38.26as on Dec 31, 2024
-
Total Equity Funding
$368.5 M (USD)
in 9 rounds
-
Latest Funding Round
$50 M (USD), Series F
Jul 07, 2020
-
Investors
SVB
& 20 more
-
Employee Count
206
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of CVRx
CVRx is a publicly listed company on the NASDAQ with ticker symbol CVRX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of CVRx
CVRx offers a comprehensive portfolio of products and services, including Barostim. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers electrical pulses to improve heart failure symptoms and quality of life.
Unlock access to complete
Unlock access to complete
Funding Insights of CVRx
CVRx has successfully raised a total of $368.5M across 9 strategic funding rounds. The most recent funding activity was a Series F round of $50 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series F — $50.0M
-
First Round
First Round
(27 Jul 2003)
- Investors Count 21
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Series F - CVRx | Valuation | Strategic Healthcare Investment Partners , Vensana Capital | |
| May, 2019 | Amount | Series F - CVRx | Valuation | Johnson & Johnson Innovation | |
| Aug, 2016 | Amount | Debt – Conventional - CVRx | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CVRx
CVRx has secured backing from 21 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, DaVita and Oxford Finance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
Ysios Capital is recognized as a leading life sciences investor.
|
Founded Year | Domain | Location | |
|
Private equity and venture captial firm focused on healthcare sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CVRx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CVRx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cvrx Comparisons
Competitors of CVRx
CVRx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sequana Medical, Adona Medical, Element Science, V-Wave and Ancora Heart, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Implantable battery-powered pumps for ascites removal are developed.
|
|
| domain | founded_year | HQ Location |
Medical devices for heart failure management are developed.
|
|
| domain | founded_year | HQ Location |
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
|
|
| domain | founded_year | HQ Location |
Implantable inter-atrial shunts are developed to treat chronic heart failure.
|
|
| domain | founded_year | HQ Location |
Minimally invasive ventriculoplasty system for heart failure and FMR
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cvrx
Frequently Asked Questions about CVRx
When was CVRx founded?
CVRx was founded in 2001 and raised its 1st funding round 2 years after it was founded.
Where is CVRx located?
CVRx is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
Is CVRx a funded company?
CVRx is a funded company, having raised a total of $368.5M across 9 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $20M, raised on Jul 27, 2003.
How many employees does CVRx have?
As of Dec 31, 2024, the latest employee count at CVRx is 206.
What is the annual revenue of CVRx?
Annual revenue of CVRx is $51.29M as on Dec 31, 2024.
What does CVRx do?
CVRx is a developer of implantable technology for hypertension and heart failure. The product Barostim neo is implanted under the skin, similar to a pacemaker. It then sends signals to the bodys cardiovascular regulators to improve cardiac and vascular function by restoring sympathovagal balance through activation of the afferent and efferent pathways of the autonomic nervous system. The product is CE marked and approved for sale in Europe for both indications.
Who are the top competitors of CVRx?
CVRx's top competitors include Sequana Medical, Adona Medical and Element Science.
What products or services does CVRx offer?
CVRx offers Barostim.
Is CVRx publicly traded?
Yes, CVRx is publicly traded on NASDAQ under the ticker symbol CVRX.
Who are CVRx's investors?
CVRx has 21 investors. Key investors include SVB, DaVita, Oxford Finance, Frazier Healthcare Partners, and Piper Jaffray.
What is CVRx's ticker symbol?
The ticker symbol of CVRx is CVRX on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.